Greater than 98% by SDS-PAGE gel and HPLC analyses.
Biological Activity:
Determined by TGF-β1’s ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells. The expected ED50 is ≤0.05 ng/ml, corresponding to a specific activity of ≥2 x 107 units/mg.